Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in TCRX — TScan Therapeutics, Inc.

CIK 1000275 TORONTO, A6
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$76
+$3 QoQ
Shares Held
78
+6.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 60 holders
Holding Since
Sep 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. TCRX ranks #399 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in TCRX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $76 78
2026-03-31 $73 73
2025-12-31 $374 374
2025-09-30 $1,466 806
2025-06-30 $99 69
2025-03-31 $1,537 1,115
2024-12-31 $6,763 2,225
2024-09-30 $61,466 12,343
2024-06-30 $21,124 3,611
2022-09-30 $561 184
2022-03-31 $2,800 1,000
2021-12-31 $4,500 1,000
2021-09-30 $8,340 1,000